Literature DB >> 11053938

Short-term hemodynamic effects of transjugular retrograde obliteration of gastric varices with gastrorenal shunt.

F Chikamori1, N Kuniyoshi, S Shibuya, Y Takase.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the short-term effects on portal hemodynamics of transjugular retrograde obliteration (TJO) of gastric varices with gastrorenal shunt.
METHODS: Thirty patients with gastric varices and a gastrorenal shunt were included in this study. The patients ranged in age from 42 to 75 years (16 men and 14 women), and according to Child's classification, class A, B and C cirrhosis was seen in 1, 13 and 16 patients, respectively. The portal blood flow was measured by an ultrasonic duplex Doppler system, and the wedged hepatic venous pressure was measured by hepatic venous catheterization, before and after TJO.
RESULTS: Complete obliteration of the gastrorenal shunt and gastric varices was revealed by retrograde inferior phrenic venography and computed tomography after TJO in all cases. The wedged hepatic venous pressure was significantly increased the day after TJO compared with that before therapy (257 +/- 71 vs. 307 +/- 73 mm H(2)O, p < 0.01). The portal venous flow was significantly increased 1 week after TJO compared with that before therapy (744 +/- 190 vs. 946 +/- 166 ml/min, p < 0.01). The serum albumin levels before and after TJO were 3.0 +/- 0.4 and 3.1 +/- 0.5 g/dl, respectively, and the total bilirubin levels were 1.5 +/- 0.7 and 1. 5 +/- 0.8 mg/dl, respectively, neither of these parameters changing significantly. The plasma ammonia levels before and after TJO were 109 +/- 62 and 67 +/- 31 microg/dl, and the indocyanine green retention rates at 15 min were 31 +/- 13 and 24 +/- 13%, both showing a significant change (p < 0.01 and p < 0.05, respectively).
CONCLUSIONS: We conclude that TJO increases portal blood flow which contributes to the decrease in plasma ammonia levels and the indocyanine green retention rate, although increasing the wedged hepatic venous pressure. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11053938     DOI: 10.1159/000018874

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  6 in total

1.  Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.

Authors:  Yasukazu Kako; Koichiro Yamakado; Wataru Jomoto; Toshiya Nasada; Koichiro Asada; Haruyuki Takaki; Kaoru Kobayashi; Takashi Daimon; Shozo Hirota
Journal:  Jpn J Radiol       Date:  2017-05-13       Impact factor: 2.374

2.  Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices.

Authors:  Hirotaka Arai; Takehiko Abe; Hitoshi Takagi; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt.

Authors:  Fumio Chikamori; Atsushi Inoue; Hiroshi Okamoto; Nobutoshi Kuniyoshi; Takahiko Kawashima; Yasuhiro Takase
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

4.  Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices.

Authors:  Jin Wook Chung
Journal:  Clin Mol Hepatol       Date:  2018-12-21

5.  The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation.

Authors:  Sung Ki Cho; Sung Wook Shin; Eun Young Yoo; Young Soo Do; Kwang Bo Park; Sung Wook Choo; Heon Han; In Wook Choo
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

6.  Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices.

Authors:  Manabu Watanabe; Kazue Shiozawa; Takashi Ikehara; Shigeru Nakano; Michio Kougame; Takafumi Otsuka; Yoshinori Kikuchi; Koji Ishii; Yoshinori Igarashi; Yasukiyo Sumino
Journal:  ISRN Gastroenterol       Date:  2012-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.